Current updates on microRNAs as regulators of chemoresistance

Çalışkan M., Güler H., Bozok Çetintaş V.

Biomedicine and Pharmacotherapy, cilt.95, ss.1000-1012, 2017 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 95
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1016/j.biopha.2017.08.084
  • Dergi Adı: Biomedicine and Pharmacotherapy
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1000-1012
  • Anahtar Kelimeler: Chemoresistance, MicroRNA, Microtubule inhibitors, Nucleoside analogues, Platinum agents, Topoisomerase inhibitors
  • Uşak Üniversitesi Adresli: Hayır

Özet

Resistance to chemotherapeutics including platinum agents, nucleoside analogues, topoisomerase and microtubule inhibitors is the most important problem in the treatment of many cancer. Several resistance mechanisms has been described for each group and researchers have been trying to develop new approaches to overcome chemoresistance. miRNAs are the regulators of gene transcription at the post-transcriptional level. Dysregulated miRNAs have been reported in cancer tumorigenesis, diagnosis and prognosis and they are promising new therapeutic approaches to improve diagnosis and predictions of outcomes and response to chemotherapy. In this article, we summarized the results from 2015 January to 2017 June which explore the roles of miRNAs in the development of the chemotherapy resistance.